SREBF2 and renal cell carcinoma: Moreover, in hepatocytes of hypercholesterolemia patients, high levels of lncRNA Activated in RCC (renal cell carcinoma) with Sunitib Resistance (lncARSR) have been found (Huang et al., 2018) where lncARSR increases the phosphorylation of AKT enhancing SREBP2 transcription (Huang et al., 2018).